HBM Partners

HBM Partners emerged in 2001 as a specialized investment firm dedicated to identifying opportunities within emerging biopharma and broader healthcare sectors. With dual expertise in both private and public market investments, the firm has established itself as a knowledgeable player in the complex healthcare investment landscape. Their comprehensive approach encompasses pharmaceuticals, biotechnology, and healthcare services, positioning them as strategic capital partners for innovative companies advancing medical solutions.

The firm's investment operations are guided by a distinguished team of industry professionals who bring extensive experience in healthcare, scientific research, and financial markets. These specialists employ rigorous methodologies to source, evaluate, and actively engage with portfolio companies across the biopharma, medical devices, and diagnostics sectors. Their hands-on investment approach often includes securing board representation and providing strategic guidance to portfolio companies, helping to navigate regulatory pathways, clinical development challenges, and commercialization strategies.

HBM Partners has built an impressive investment track record comprising over 100 healthcare investments since inception. This portfolio has generated substantial returns through more than 60 successful exits via trade sales and initial public offerings. Notable among these are investments in breakthrough therapeutic companies, innovative medical technology developers, and diagnostic pioneers that have transformed patient care standards. This performance history demonstrates the firm's ability to identify promising healthcare innovations and support their development into commercially viable enterprises.

As a FINMA-regulated investment advisor, HBM Partners maintains strict compliance with Swiss financial regulations while managing a diverse range of investment vehicles. Their flagship relationship involves advising HBM Healthcare Investments, a SIX Swiss Exchange-listed investment company focused on healthcare opportunities. Beyond this, the firm oversees specialized public and private equity investment products tailored to various investor needs and risk profiles. This institutional framework allows HBM to deploy capital across different stages of company development, from early-stage ventures to established healthcare enterprises poised for significant growth.